Toggle SGML Header (+)


Section 1: 8-K (8-K)

ingn-8k_20180216.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8‑K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

February 13, 2018

 

INOGEN, INC.

(Exact name of registrant as specified in its charter)

Delaware

 

001-36309

 

33-0989359

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

326 Bollay Drive

Goleta, California 93117

(Address of principal executive offices, including zip code)

(805) 562-0500

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

 


Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 13, 2018, the Compensation, Nominating and Governance Committee of the Board of Directors of Inogen, Inc. (the “Company”) approved annual base salaries for fiscal 2018 for the Company’s principal executive officer, principal financial officer, and certain named executive officers, each as more fully set forth below:

 

 

 

 

 

Annual Base Salary

 

 

Annual Base Salary

 

Name

 

Position

 

(Fiscal 2017)

 

 

(Fiscal 2018) (1)

 

Scott Wilkinson

 

Chief Executive Officer and President

 

$

415,000

 

 

$

499,000

 

Alison Bauerlein

 

Executive Vice President, Finance,

 

$

340,000

 

 

$

355,000

 

 

 

Chief Financial Officer, Corporate

 

 

 

 

 

 

 

 

 

 

Secretary and Corporate Treasurer

 

 

 

 

 

 

 

 

Matthew Scribner

 

Executive Vice President, Operations

 

$

295,000

 

 

$

303,000

 

Brenton Taylor

 

Executive Vice President, Engineering

 

$

300,000

 

 

$

310,000

 

 

 

 

 

 

 

 

 

 

 

 

(1) Base salary increases are effective as of February 12, 2018.

 

 

 

 

 

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

INOGEN, INC.

 

 

 

 

By:

/s/Alison Bauerlein

 

 

Alison Bauerlein

Executive Vice President, Finance, Chief

Financial Officer, Corporate Secretary and Corporate Treasurer

Date:  February 16, 2018

 

(Back To Top)